Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2026-05-29 @ 12:48 AM
Study NCT ID:
NCT01290692
Status:
COMPLETED
Last Update Posted:
2023-07-03
First Post:
2011-02-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Sponsor:
TVAX Biomedical
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Brain Neoplasms | View |
| None | Central Nervous System Neoplasms | View |
| None | Brain Diseases | View |
| None | Neoplasms | View |
| None | Nervous System Neoplasms | View |
| None | Glioblastoma | View |
| None | Astrocytoma | View |
| None | Nervous System Diseases | View |
| None | Central Nervous System Diseases | View |
| None | Glioma | View |
| None | Recurrent astrocytoma | View |
| None | Recurrent glioma | View |
| None | Cancer vaccine | View |
| None | Immunotherapy | View |
| None | Killer T cells | View |
| None | Activated T cells | View |
| None | GM-CSF | View |
| None | Activated lymphocytes | View |